miR-25-3p Inhibition Alleviates Alzheimer's Neuroinflammation by Targeting ADAM10 in Cell Models
Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10.
Abstract
Inhibiting miR-25-3p reduced Aβ25-35-induced neurotoxicity and inflammation in AD cell models by targeting ADAM10, suggesting a novel therapeutic axis for Alzheimer's disease.